Literature DB >> 19404653

Absence of alpha-synuclein pathology in postencephalitic parkinsonism.

Kurt A Jellinger1.   

Abstract

Postencephalitic parkinsonism (PEP), a chronic complication of encephalitis lethargica, is a tauopathy characterized by multisystem neuronal loss and gliosis with widespread neurofibrillary lesions composed of both 3- and 4-repeat (3R and 4R) tau isoforms. Previous immunohistochemical studies in a small number of PEP cases demonstrated absence of Lewy bodies as well as the lack of other alpha-synuclein pathology, classifying PEP as a "pure" tauopathy. Neuropathologic examination of 10 brains with clinico-pathologically verified PEP confirmed widespread neurodegeneration in subcortical and brainstem areas associated with multifocal neurofibrillary pathology comprising both 3R and 4R tau. Very rare beta-amyloid deposits were observed in two elderly patients, while Lewy bodies and neurites or any other alpha-synuclein deposits were completely absent. The causes and molecular background of total absence of alpha-synuclein pathology in PEP, in contrast to most other tauopathies, remain as unknown as the pathogenesis of PEP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19404653     DOI: 10.1007/s00401-009-0537-9

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  12 in total

1.  Powassan virus postencephalitic parkinsonism.

Authors:  Shivam Om Mittal; Anhar Hassan; Joyce Sanchez; Carrie Robertson
Journal:  Neurol Clin Pract       Date:  2017-12

Review 2.  Roles of tau protein in health and disease.

Authors:  Tong Guo; Wendy Noble; Diane P Hanger
Journal:  Acta Neuropathol       Date:  2017-04-06       Impact factor: 17.088

Review 3.  α-Synuclein in Parkinson's disease: causal or bystander?

Authors:  Peter Riederer; Daniela Berg; Nicolas Casadei; Fubo Cheng; Joseph Classen; Christian Dresel; Wolfgang Jost; Rejko Krüger; Thomas Müller; Heinz Reichmann; Olaf Rieß; Alexander Storch; Sabrina Strobel; Thilo van Eimeren; Hans-Ullrich Völker; Jürgen Winkler; Konstanze F Winklhofer; Ullrich Wüllner; Friederike Zunke; Camelia-Maria Monoranu
Journal:  J Neural Transm (Vienna)       Date:  2019-06-25       Impact factor: 3.575

4.  Disruption of cellular proteostasis by H1N1 influenza A virus causes α-synuclein aggregation.

Authors:  Rita Marreiros; Andreas Müller-Schiffmann; Svenja V Trossbach; Ingrid Prikulis; Sebastian Hänsch; Stefanie Weidtkamp-Peters; Ana Raquel Moreira; Shriya Sahu; Irina Soloviev; Suganya Selvarajah; Vishwanath R Lingappa; Carsten Korth
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-09       Impact factor: 11.205

5.  Classification of diseases with accumulation of Tau protein.

Authors:  Gabor G Kovacs; Bernardino Ghetti; Michel Goedert
Journal:  Neuropathol Appl Neurobiol       Date:  2022-02-09       Impact factor: 6.250

Review 6.  Alpha-synuclein and tau: teammates in neurodegeneration?

Authors:  Simon Moussaud; Daryl R Jones; Elisabeth L Moussaud-Lamodière; Marion Delenclos; Owen A Ross; Pamela J McLean
Journal:  Mol Neurodegener       Date:  2014-10-29       Impact factor: 14.195

7.  Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PR EDIGT score.

Authors:  Michael G Schlossmacher; Julianna J Tomlinson; Goncalo Santos; Bojan Shutinoski; Earl G Brown; Douglas Manuel; Tiago Mestre
Journal:  Eur J Neurosci       Date:  2016-12-27       Impact factor: 3.386

Review 8.  The Role of Insulin/IGF-1/PI3K/Akt/GSK3β Signaling in Parkinson's Disease Dementia.

Authors:  Liying Yang; Hongyan Wang; Lijun Liu; Anmu Xie
Journal:  Front Neurosci       Date:  2018-02-20       Impact factor: 4.677

9.  Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms.

Authors:  V A Blanco-Palmero; F J Azcárate-Díaz; M Ruiz-Ortiz; M I Laespada-García; P Rábano-Suárez; A Méndez-Guerrero; M Aramendi-Ramos; J L Eguiburu; A Pérez-Rivilla; A Marchán-López; M Rubio-Fernández; E Carro; J González de la Aleja
Journal:  J Neurol       Date:  2021-02-19       Impact factor: 4.849

10.  Neurodegenerative proteinopathies associated with neuroinfections.

Authors:  Krisztina Danics; Shelley L Forrest; Istvan Kapas; Irene Erber; Susanne Schmid; Klára Törő; Katalin Majtenyi; Gabor G Kovacs
Journal:  J Neural Transm (Vienna)       Date:  2021-07-05       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.